Akari Therapeutics Announces Further Clinical Trial Progress Using Nomacopan to Treat COVID-19 Pneumonia

NEXT STORY
Dental Implants Market to Exhibit 5.1% CAGR and Reach USD 5725 Million by 2026; Straumann to Dominate with its Diverse Product Portfolio, says Fortune Business Insights
PREV STORY
Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zai Lab Announces Upcoming Presentation at 39th Annual J.P. Morgan Healthcare Conference

author_avatar
NASDAQ Market News

Zai Lab Partner, GSK, Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer

author_avatar
NASDAQ Market News

TELUS Health virtual care now integrated into electronic medical records across Canada

author_avatar
NASDAQ Market News